Park, J. H., Palomba, M. L., Perica, K., Devlin, S. M., Shah, G., Dahi, P. B., Lin, R. J., Salles, G., Scordo, M., Nath, K., Valtis, Y. K., Lynch, A., Cathcart, E., Zhang, H., Schoder, H., Leithner, D., Liotta, K., Yu, A., Stocker, K., Li, J., Dey, A., Sellner, L., Singh, R., Sundaresan, V., Tong, X., Zhao, F., Mansilla-Soto, J., He, C., Meyerson, J., Hosszu, K., McAvoy, D., Wang, X., Rivière, I., Sadelain, M. (2025). Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02424